| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT06975787 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… |
date change Primary completion pushed: 2028-07-23 -> 2029-09-09 |
| 2026-06-09 | NCT06975787 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… |
date change Completion pushed: 2028-07-23 -> 2029-09-09 |
| 2026-06-03 | NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients… |
Trial completed |
| 2026-06-03 | NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients… |
date change Primary completion moved earlier: 2026-05-31 -> 2026-04-29 |
| 2026-06-03 | NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients… |
date change Completion moved earlier: 2026-05-31 -> 2026-04-29 |
| 2026-05-16 | NCT06091865 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… |
overall status: "Active Not Recruiting" → "Recruiting" |
| 2026-05-16 | NCT06091865 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… |
Trial sites expanded: 149 -> 155 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06149286 | A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better… | Relapsed/Refractory Follicular Lymphoma | Recruiting |
| NCT06091865 | A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… | Diffuse Large B-cell Lymphoma (DLBCL) | Recruiting |
| NCT06091254 | A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works… | Follicular Lymphoma (FL) | Recruiting |
| NCT06097364 | A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated… | Follicular Lymphoma (FL) | Active, Not Recruiting |
| NCT06230224 | A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for… | B-Cell Non-Hodgkin Lymphoma (B-NHL) | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05991388 | A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory… | B-cell Non Hodgkin Lymphoma | Recruiting |
| Phase 2 | |||
| NCT07128641 | Odronextamab in Low Tumor Volume Advanced FL | Follicular Lymphoma | Recruiting |
| NCT06784726 | Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T | Recurrent Diffuse Large B-Cell Lymphoma | Recruiting |
| Phase 1 | |||
| NCT05685173 | A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult… | B-cell Non-Hodgkins Lymphoma (B-NHL) | Recruiting |
| NCT06975787 | Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… | Lupus Nephritis (LN) | Recruiting |